Internal Medicine Alert – January 15, 2013
January 15, 2013
View Issues
-
Daily Coffee Consumption: A New Frontier in Diabetes Prevention!
Regardless of the caffeine status, coffee intake was associated with reduced risk of type 2 diabetes while sugar-sweetened beverages were associated with a higher risk. -
Using Low-Dose Aspirin to Prevent Recurrent Venous Thromboembolism
Aspirin therapy, as compared with placebo, significantly reduced the rate of major vascular events with improved net clinical benefit and also reduced the rate of recurrent venous thromboembolism. -
At Last...Type 1 Diabetes Can Be Prevented (But Only in Rats)!
The author reviewed the strategies of predicting and preventing type 1 diabetes across the different stages of development of the disorder. Not only can risk for type 1 diabetes be predicted, but the approximate age of diabetes onset in children can be ascertained. -
Pharmacology Update: Ingenol Mebutate Gel (Picato)
A new topical agent is available for the treatment of actinic keratosis (AK). Ingenol mebutate is a macrocyclic diterpene ester found in the sap of Euphorbia peplus, a common plant found in Africa, Europe, and Asia. -
Clinical Briefs By Louis Kuritzky, MD
Does Screening for Type 2 Diabetes Pay Off?; Surgical Treatment of Diabetes; Benefits and Consequences of Aldosterone Antagonists for HF -
ECG Review: Early Repolarization or Anterior STEMI?
The 12-lead ECG shown above was obtained from a 50-year-old man with new-onset chest pain. Is this ECG likely to represent a benign early repolarization pattern or the early stage of acute anterior ST elevation myocardial infarction (STEMI)? -
Pharmacology Watch: Zolpidem and Risk of Falls in Hospitalized Patients
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.